Art

J-GLOBAL ID：201702262448713745   Reference number：17A1131994

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

骨粗鬆症の閉経後女性におけるデノスマブ治療の10年間:第3相無作為化自由試験および非盲検拡大試験の結果【Powered by NICT】

Author (22)： Bone Henry G (Michigan Bone and Mineral Clinic, Detroit, MI, USA) ,  Bone Henry G (Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Harbor, MI, USA) ,  Wagman Rachel B (Research and Development, Amgen, Thousand Oaks, CA, USA) ,  Brandi Maria L (Department of Surgery and Translational Medicine, University of Florence, Florence, Italy) ,  Brown Jacques P (Department of Medicine, Laval University and CHU de Quebec Research Centre, Quebec City, QC, Canada) ,  Chapurlat Roland (INSERM UMR 1033, Universite de Lyon, Hopital Edouard Herriot, Lyon, France) ,  Cummings Steven R (San Francisco Coordinating Center, CPMC Research Institute, UCSF, San Francisco, CA, USA) ,  Czerwinski Edward (Krakow Medical Centre, Krakow, Poland) ,  Fahrleitner-Pammer Astrid (Department of Endocrinology and Metabolism, Medical University Graz, Graz, Austria) ,  Kendler David L (Department of Medicine, Division of Endocrinology, University of British Columbia, Vancouver, BC, Canada) ,  Lippuner Kurt (Department of Osteoporosis, Bern University Hospital, Bern, Switzerland) ,  Reginster Jean-Yves (Bone and Cartilage Metabolism Unit, University of Liege, Liege, Belgium) ,  Roux Christian (Department of Rheumatology, Paris Descartes University, Paris, France) ,  Malouf Jorge (Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain) ,  Bradley Michelle N (Research and Development, Amgen, Thousand Oaks, CA, USA) ,  Daizadeh Nadia S (Research and Development, Amgen, Thousand Oaks, CA, USA) ,  Wang Andrea (Research and Development, Amgen, Thousand Oaks, CA, USA) ,  Dakin Paula (Research and Development, Amgen, Thousand Oaks, CA, USA) ,  Pannacciulli Nicola (Research and Development, Amgen, Thousand Oaks, CA, USA) ,  Dempster David W (Department of Pathology and Cell Biology, Columbia University, New York, NY, USA) ,  Dempster David W (Regional Bone Center, Helen Hayes Hospital, West Haverstraw, NY, USA) ,  Papapoulos Socrates (Center for Bone Quality, Leiden University Medical Center, Leiden, Netherlands)
Material： Lancet Diabetes & Endocrinology
Volume： 5  Issue： 7  Page： 513-523  Publication year： 2017 
JST Material Number： W3110A  ISSN： 2213-8587  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Long-term safety and efficacy ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1131994&from=J-GLOBAL&jstjournalNo=W3110A") }}

Thesaurus term： Europe ,  double blind test ,  *osteoporosis ,  Hip Joint ,  Bone Density ,  *woman ,  placebo ,  Safety ,  evaluation criterion ,  *therapy ,  Lumbar Vertebrae ,  fracture (disease) ,  damage and injury
Semi thesaurus term： 発生率 ,  *デノスマブ ,  *閉経後女性 , 【Automatic Indexing@JST】

JST classification (2)： Clinical application of other drugs acting on metabolism  (GW13070T) ,  Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D)

Terms in the title (7)： 骨粗鬆症 ,  閉経後女性 ,  デノスマブ ,  治療 ,  3相 ,  試験 ,  盲